NO333251B1 - Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidoner - Google Patents
Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidonerInfo
- Publication number
- NO333251B1 NO333251B1 NO20055226A NO20055226A NO333251B1 NO 333251 B1 NO333251 B1 NO 333251B1 NO 20055226 A NO20055226 A NO 20055226A NO 20055226 A NO20055226 A NO 20055226A NO 333251 B1 NO333251 B1 NO 333251B1
- Authority
- NO
- Norway
- Prior art keywords
- reaction
- preparation
- resulting compound
- substituted
- cyanopyrrolidones
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 238000002955 isolation Methods 0.000 abstract 2
- VLJNHYLEOZPXFW-BYPYZUCNSA-N L-prolinamide Chemical compound NC(=O)[C@@H]1CCCN1 VLJNHYLEOZPXFW-BYPYZUCNSA-N 0.000 abstract 1
- -1 N- (N'-substituted glycyl) -2-cyanopyrrolidine Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000012024 dehydrating agents Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0308854A GB0308854D0 (en) | 2003-04-16 | 2003-04-16 | Organic compounds |
| GB0311836A GB0311836D0 (en) | 2003-05-22 | 2003-05-22 | Process for the manufacture of organic compounds |
| PCT/EP2004/003980 WO2004092127A1 (en) | 2003-04-16 | 2004-04-15 | Process for the preparation of n-substituted 2-cyanopyrrolidines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055226L NO20055226L (no) | 2005-11-07 |
| NO333251B1 true NO333251B1 (no) | 2013-04-22 |
Family
ID=33301223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055226A NO333251B1 (no) | 2003-04-16 | 2005-11-07 | Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidoner |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US7375238B2 (is) |
| EP (1) | EP1620396B1 (is) |
| JP (1) | JP4672647B2 (is) |
| KR (1) | KR101192538B1 (is) |
| AR (1) | AR044019A1 (is) |
| AU (2) | AU2004230245B2 (is) |
| BR (1) | BRPI0409471B8 (is) |
| CA (1) | CA2520128C (is) |
| CL (1) | CL2004000804A1 (is) |
| CO (1) | CO5700735A2 (is) |
| CY (1) | CY1116008T1 (is) |
| DK (1) | DK1620396T3 (is) |
| EC (1) | ECSP056093A (is) |
| ES (1) | ES2531084T3 (is) |
| HK (1) | HK1087695A1 (is) |
| HR (1) | HRP20150163T1 (is) |
| IL (1) | IL170887A (is) |
| IS (1) | IS2979B (is) |
| MA (1) | MA27765A1 (is) |
| MX (1) | MXPA05011073A (is) |
| MY (1) | MY139476A (is) |
| NO (1) | NO333251B1 (is) |
| NZ (1) | NZ542899A (is) |
| PE (2) | PE20081293A1 (is) |
| PL (1) | PL1620396T3 (is) |
| PT (1) | PT1620396E (is) |
| RU (1) | RU2369598C2 (is) |
| SG (1) | SG160212A1 (is) |
| SI (1) | SI1620396T1 (is) |
| TW (1) | TWI359135B (is) |
| WO (1) | WO2004092127A1 (is) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR044019A1 (es) | 2003-04-16 | 2005-08-24 | Novartis Ag | Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas |
| EP2165703A3 (en) | 2004-01-20 | 2012-03-28 | Novartis Pharma AG | Direct compression formulation and process |
| GT200600008A (es) | 2005-01-18 | 2006-08-09 | Formulacion de compresion directa y proceso | |
| MX2008001609A (es) * | 2005-08-04 | 2008-02-19 | Novartis Ag | Sales de vildagliptina. |
| JP5165584B2 (ja) * | 2006-11-29 | 2013-03-21 | 田辺三菱製薬株式会社 | Ｎ−（ｎ’−置換グリシル）−２−シアノピロリジン誘導体の製法 |
| WO2008084383A2 (en) * | 2007-01-10 | 2008-07-17 | Medichem, S.A. | Process for preparing vildagliptin |
| CZ2008512A3 (cs) | 2008-08-26 | 2010-03-10 | Zentiva, A. S | Zpusob prípravy vysoce cistého vildagliptinu |
| EA034049B1 (ru) * | 2009-07-31 | 2019-12-23 | КРКА, д.д., НОВО МЕСТО | Гранулят, включающий вилдаглиптин, способ его получения и фармацевтическая композиция |
| HUP0900638A2 (en) * | 2009-10-07 | 2011-05-30 | Egyt Gyogyszervegyeszeti Gyar | Adducts of inorganic salts basea on vildaelitpin applicable for preparation of pharmaceutical compositions |
| IT1400714B1 (it) | 2010-07-06 | 2013-06-28 | Chemelectiva S R L | Processo ed intermedi per la preparazione di un principio attivo. |
| HU231050B1 (hu) | 2010-08-19 | 2020-02-28 | Egis Gyógyszergyár Nyrt. | Eljárás gyógyszerhatóanyag előállítására |
| ITMI20112224A1 (it) * | 2011-12-06 | 2013-06-07 | Chemelectiva S R L | Nuovo processo ed intermedi per la sintesi di vildagliptin |
| IN2012MU01383A (is) * | 2012-05-04 | 2014-02-28 | ||
| CN103922986B (zh) * | 2013-01-16 | 2017-02-15 | 上海彩迩文生化科技有限公司 | 维大列汀及其类似物、中间体及其制备方法和应用 |
| WO2015145467A1 (en) * | 2014-03-28 | 2015-10-01 | Laurus Labs Private Limited | An improved process for preparing vildagliptin |
| WO2021234430A1 (en) | 2020-05-17 | 2021-11-25 | Lotus International Pte. Ltd. | Modified release dosage form comprising vildagliptin and process for manufacturing the same |
| WO2022003405A1 (en) | 2020-07-03 | 2022-01-06 | Savoi Guilherme | One-pot process to obtain a pyrrolidine-2-carbonitrile intermediate compound and industrial scale telescopic process to prepare (2s)-1-[n-(3-hydroxyadamantan-1-yl)glycyl]-2-pyrrolidinecarbonitrile (vildagliptin) using same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5510369A (en) * | 1994-07-22 | 1996-04-23 | Merck & Co., Inc. | Pyrrolidine thrombin inhibitors |
| TW492957B (en) * | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
| CO5150173A1 (es) * | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| US6380398B2 (en) | 2000-01-04 | 2002-04-30 | Novo Nordisk A/S | Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV |
| EP1254113A1 (en) * | 2000-01-24 | 2002-11-06 | Novo Nordisk A/S | N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
| TW583185B (en) * | 2000-06-13 | 2004-04-11 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same |
| JP2002265439A (ja) * | 2001-03-08 | 2002-09-18 | Mitsubishi Pharma Corp | シアノピロリジン誘導体およびその医薬用途 |
| AR044019A1 (es) | 2003-04-16 | 2005-08-24 | Novartis Ag | Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas |
-
2004
- 2004-04-14 AR ARP040101251A patent/AR044019A1/es not_active Application Discontinuation
- 2004-04-14 PE PE2007000421A patent/PE20081293A1/es not_active Application Discontinuation
- 2004-04-14 PE PE2004000370A patent/PE20050021A1/es not_active Application Discontinuation
- 2004-04-15 MX MXPA05011073A patent/MXPA05011073A/es active IP Right Grant
- 2004-04-15 MY MYPI20041383A patent/MY139476A/en unknown
- 2004-04-15 SG SG200716949-3A patent/SG160212A1/en unknown
- 2004-04-15 JP JP2006505132A patent/JP4672647B2/ja not_active Expired - Lifetime
- 2004-04-15 US US10/552,835 patent/US7375238B2/en not_active Expired - Fee Related
- 2004-04-15 AU AU2004230245A patent/AU2004230245B2/en not_active Ceased
- 2004-04-15 CA CA2520128A patent/CA2520128C/en not_active Expired - Fee Related
- 2004-04-15 DK DK04727557.3T patent/DK1620396T3/en active
- 2004-04-15 KR KR1020057019568A patent/KR101192538B1/ko active IP Right Review Request
- 2004-04-15 WO PCT/EP2004/003980 patent/WO2004092127A1/en active Application Filing
- 2004-04-15 PL PL04727557T patent/PL1620396T3/pl unknown
- 2004-04-15 SI SI200432220T patent/SI1620396T1/sl unknown
- 2004-04-15 NZ NZ542899A patent/NZ542899A/en not_active IP Right Cessation
- 2004-04-15 RU RU2005135331/04A patent/RU2369598C2/ru active
- 2004-04-15 TW TW093110566A patent/TWI359135B/zh not_active IP Right Cessation
- 2004-04-15 BR BRPI0409471A patent/BRPI0409471B8/pt not_active IP Right Cessation
- 2004-04-15 CL CL200400804A patent/CL2004000804A1/es unknown
- 2004-04-15 PT PT04727557T patent/PT1620396E/pt unknown
- 2004-04-15 EP EP04727557.3A patent/EP1620396B1/en not_active Expired - Lifetime
- 2004-04-15 ES ES04727557T patent/ES2531084T3/es not_active Expired - Lifetime
-
2005
- 2005-09-15 IL IL170887A patent/IL170887A/en active IP Right Grant
- 2005-10-12 EC EC2005006093A patent/ECSP056093A/es unknown
- 2005-10-19 MA MA28559A patent/MA27765A1/fr unknown
- 2005-11-03 CO CO05112189A patent/CO5700735A2/es not_active Application Discontinuation
- 2005-11-07 NO NO20055226A patent/NO333251B1/no not_active IP Right Cessation
- 2005-11-10 IS IS8122A patent/IS2979B/is unknown
-
2006
- 2006-07-11 HK HK06107769.8A patent/HK1087695A1/xx not_active IP Right Cessation
-
2008
- 2008-05-22 AU AU2008202278A patent/AU2008202278A1/en not_active Abandoned
-
2015
- 2015-02-10 HR HRP20150163TT patent/HRP20150163T1/hr unknown
- 2015-02-18 CY CY20151100168T patent/CY1116008T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO333251B1 (no) | Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidoner | |
| EA200970171A1 (ru) | Производные n-(аминогетероарил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
| TR200103497T2 (tr) | Beta2-adrenoseptör agonistler. | |
| NO20053890L (no) | Syntese av 4-amino-2-butenolklorider og anvendelse derav for fremstilling av 3-cyanokinoliner | |
| EA200700545A1 (ru) | Производные изоксазолина и их применение в качестве гербицидов | |
| EE200200070A (et) | Raku adhesiooni inhibiitorid | |
| NO331165B1 (no) | Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter | |
| NO20050650L (no) | Fremgangsmate for selektiv fremstilling av aryl-5-tio- -D-aldoheksopyranosider | |
| NO20031561L (no) | Kjemiske forbindelser | |
| NO20053246L (no) | Kondensert 1,3-dihydroimidazol-ringforbindelse. | |
| NO20060703L (no) | Fremgangsmate for fremstilling av cis-4-fluor-1-prolinderivater | |
| NO20054787L (no) | Indenderivater som farmasotiske midler | |
| BRPI0414738A (pt) | derivados de ácido acético substituìdos | |
| BR0014199A (pt) | Derivados de bifenila como inibidores de nhe-3 | |
| NO20082077L (no) | Spirosykliske quinazolinderivater som PDE7-inhibitorer | |
| NO985335L (no) | 2,4-Diaminopyrimidinderivater | |
| MY138051A (en) | Compounds and processes | |
| HUP0201475A2 (hu) | Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
| YU46706B (sh) | Postupak za dobijanje amidnih jedinjenja | |
| TNSN05261A1 (en) | Process for the preparation of n-substituted 2-cyanopyrrolidines | |
| NO20016267L (no) | Nye kvatern¶re ammoniumforbindelser, en fremgangsmåte for fremstilling av dem og den farmasöytiske anvendelse derav | |
| EE05136B1 (et) | Asendatud imidasopridiinhendite valmistamise meetod | |
| ATE28858T1 (de) | Derivate von n-(methoxyphenacyl)aminen, ihre therapeutische verwendung und verfahren zu ihrer herstellung. | |
| NO20010332D0 (no) | Nye 6-deoksyerytromycinderivater, metoder for fremstilling av disse, og anvendelse som medisiner | |
| DE50206142D1 (de) | Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |